Navigation Links
Harlan Laboratories Continues Strategic Growth with Expansion of South European Services Facility
Date:9/12/2013

INDIANAPOLIS, Sept. 12, 2013 /PRNewswire/ -- Harlan Laboratories, a leading contract research organization and research models and services company, announced today that the company has expanded its specialty research production facility in Southern Europe. The expansion allows Harlan Laboratories to provide its complete portfolio of contract breeding and health monitoring services to customers in both mainland Europe and the U.K.

"Expanding our facility in Southern Europe is a significant part of our global growth strategy to provide pharmaceutical and biotech companies throughout Europe with the highest quality services that support their research models," said Joe Meyer, Vice President of Global Commercial Operations, Harlan Laboratories. "The expansion of our contract breeding and health monitoring services facility reinforces Harlan Laboratories' commitment to provide researchers around the globe with critical services that ensure the specialized models they use in their research will produce reliable and consistent results."  

The expanded Southern European operations were designed to mirror Harlan's contract breeding service capabilities already established in the U.K. These services include rederivation, cryopreservation, revitalization, colony management, contract breeding and quarantine services.

As with all of Harlan Laboratories' production facilities, the new site was designed with the utmost consideration for the health and welfare of research models. The enhanced facility includes dedicated areas for quarantine to reduce the transmission of pathogens between animal colonies and also features an expanded and updated health monitoring laboratory. In addition, Harlan Laboratories incorporated the LabTracks software system, by Locus Technology, Inc., which provides a fully integrated animal husbandry network that supports real-time inventory data, records on cryopreserved materials, as well as information on cage capacity and the health status of animals within the facility. 

The Southern European facility expansion comes on the heels of Harlan Laboratories' recent announcement that the company has increased its specialty model production capacity in North America by more than 30 percent with expansions of its facilities in Indianapolis, Indiana and Livermore, California.

For more information on Harlan Laboratories, please visit www.Harlan.com.

About Harlan Laboratories, Inc.
Harlan Laboratories, Inc. is a leading provider of essential, pre-clinical and non-clinical contract research, research models, animal diets, and services to the pharmaceutical, biotech, medical device, agrochemical and chemical industries, as well as universities, government, and other research organizations. Our focus is on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. Harlan Laboratories is a privately held company.                                           

PRESS CONTACT: 
Michael Clark 
Miller Brooks, Inc. 
317.873.8100
michael@millerbrooks.com


'/>"/>
SOURCE Harlan Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Harlan Laboratories Continues Global Growth with Major Expansion of North American Facilities
2. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
3. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
4. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
5. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
6. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
7. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
8. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
9. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
10. Court Preliminarily Deems Millennium Laboratories Press Release Misleading
11. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2017)... , July 5, 2017 Oramed ... www.oramed.com ), a clinical-stage pharmaceutical company focused on ... it has received approval from the Israel Securities Authority to ... (TASE). Oramed common stock will commence trading on the TASE ... the current market capitalization of the Company, it is expected ...
(Date:7/1/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ... be broadcast live over the Internet on Thursday, July 27, ... the quarterly results will be made available at 7:30 a.m. ... The live audio webcast can be accessed via Zimmer Biomet,s ... archived for replay following the conference call. ...
(Date:6/30/2017)... , June 29, 2017  Axium Pharmaceuticals Inc. is a pharmaceutical ... novel formulations and alternative dosage forms of existing biologically active ... ... on our waterless self-nano emulsifying formula, which is designed to ... We believe the spray will provide fast onset of action ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... ... financial planning services to communities in the greater Birmingham area, is joining the ... to underprivileged young people in the region. , The Chris Hammond Youth Foundation ...
(Date:7/21/2017)... ... July 21, 2017 , ... Fresh Wave® IAQ today announced the launch of ... colleges and universities at the APPA 2017 Annual Conference and Exhibition in ... smoke odors without the use of harsh chemicals, Fresh Wave IAQ Smoke Away Air ...
(Date:7/21/2017)... ... July 21, 2017 , ... Hospital M&A activity slowed ... . The number of hospital acquisitions rose to 23 in the second quarter, up ... up 15% from the 20 announced deals in the year-ago second quarter. Only four ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm ... the contents of its ginger ale for allegedly containing no ginger. Dr. Pepper produces ... Snapple Group, Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its ...
(Date:7/21/2017)... ... July 21, 2017 , ... The ... grant from the C. R. Bard Foundation, Inc. to support the ... , a service available through the nonprofit home care agency. Using evidence-based methods, ...
Breaking Medicine News(10 mins):